West Pharmaceutical Services Earnings & Revenue FAQ
What were WST's earnings last quarter?
On Invalid Date, West Pharmaceutical Services (NYSE: WST) reported Q4 2023 earnings per share (EPS) of $1.85, up 34.06% year over year. Total West Pharmaceutical Services earnings for the quarter were $137.00 million. In the same quarter last year, West Pharmaceutical Services's earnings per share (EPS) was $1.38.
As of Q2 2024, West Pharmaceutical Services's earnings has grown 1.4% year over year. This is 21.53 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 22.93%. West Pharmaceutical Services's earnings in the past year totalled $593.40 million.
What is WST's earnings date?
West Pharmaceutical Services's earnings date is Invalid Date. Add WST to your watchlist to be reminded of WST's next earnings announcement.
What was WST's revenue last quarter?
On Invalid Date, West Pharmaceutical Services (NYSE: WST) reported Q4 2023 revenue of $732.00 million up 3.29% year over year. In the same quarter last year, West Pharmaceutical Services's revenue was $708.70 million.
What was WST's revenue growth in the past year?
As of Q2 2024, West Pharmaceutical Services's revenue has grown 2.18% year over year. This is 5.8 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.98%. West Pharmaceutical Services's revenue in the past year totalled $2.95 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.